News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EpiCept Corporation And Maxim Pharmaceuticals, Inc. (MAXM) Announce Trading And Listing Mechanics Upon Closing Of The Merger


12/28/2005 11:26:04 AM

)--Dec. 28, 2005--As previously reported on December 21, 2005 the stockholders of Maxim Pharmaceuticals, Inc. (Maxim) (NASDAQ:MAXM)(SSE:MAXM) approved and adopted the Agreement and Plan of Merger between EpiCept Corporation (EpiCept) and Maxim and approved the merger. EpiCept's stockholders had previously voted to approve the merger agreement and the issuance of the EpiCept common stock to Maxim's stockholders in the merger.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES